| Ornob Proteek Roy, MD | |
|
1225 Harding Pl, Ste 3100, Charlotte, NC 28204-2826 | |
| (704) 355-8686 | |
| Not Available |
| Full Name | Ornob Proteek Roy |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 19 Years |
| Location | 1225 Harding Pl, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891908430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 2011-00979 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Atrium Health Union | Monroe, NC | Hospital |
| Carolinas Medical Center-pineville | Charlotte, NC | Hospital |
| Atrium Health Lincoln | Lincolnton, NC | Hospital |
| Atrium Health University City | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Medical Center | 4789597477 | 735 |
News Archive
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
The University of Pennsylvania Upstart Program announces TransCare Partners LLC to broaden the use of the Transitional Care Model developed at the University of Pennsylvania School of Nursing. The Model, developed over 20 years by Dr Mary Naylor, has been clinically proven to reduce hospital re- admissions by up to 30% while producing substantial savings for hospitals and Medicare.
Unitrin, Inc. today announced that it has reached an agreement in principle to sell its health insurance subsidiary, Reserve National Insurance Company, to Physicians Mutual®. The transaction is subject to negotiation and execution of a definitive purchase agreement, completion of due diligence and regulatory approval. The transaction is expected to be completed in the second quarter of 2010. Terms of the transaction were not announced.
› Verified 3 days ago
| Entity Name | Carolinas Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774333 PECOS PAC ID: 4789597477 Enrollment ID: O20031110000116 |
News Archive
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
The University of Pennsylvania Upstart Program announces TransCare Partners LLC to broaden the use of the Transitional Care Model developed at the University of Pennsylvania School of Nursing. The Model, developed over 20 years by Dr Mary Naylor, has been clinically proven to reduce hospital re- admissions by up to 30% while producing substantial savings for hospitals and Medicare.
Unitrin, Inc. today announced that it has reached an agreement in principle to sell its health insurance subsidiary, Reserve National Insurance Company, to Physicians Mutual®. The transaction is subject to negotiation and execution of a definitive purchase agreement, completion of due diligence and regulatory approval. The transaction is expected to be completed in the second quarter of 2010. Terms of the transaction were not announced.
› Verified 3 days ago
| Entity Name | Stone Institute Of The Carolinas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457377954 PECOS PAC ID: 3173412533 Enrollment ID: O20040312001126 |
News Archive
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
The University of Pennsylvania Upstart Program announces TransCare Partners LLC to broaden the use of the Transitional Care Model developed at the University of Pennsylvania School of Nursing. The Model, developed over 20 years by Dr Mary Naylor, has been clinically proven to reduce hospital re- admissions by up to 30% while producing substantial savings for hospitals and Medicare.
Unitrin, Inc. today announced that it has reached an agreement in principle to sell its health insurance subsidiary, Reserve National Insurance Company, to Physicians Mutual®. The transaction is subject to negotiation and execution of a definitive purchase agreement, completion of due diligence and regulatory approval. The transaction is expected to be completed in the second quarter of 2010. Terms of the transaction were not announced.
› Verified 3 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
The University of Pennsylvania Upstart Program announces TransCare Partners LLC to broaden the use of the Transitional Care Model developed at the University of Pennsylvania School of Nursing. The Model, developed over 20 years by Dr Mary Naylor, has been clinically proven to reduce hospital re- admissions by up to 30% while producing substantial savings for hospitals and Medicare.
Unitrin, Inc. today announced that it has reached an agreement in principle to sell its health insurance subsidiary, Reserve National Insurance Company, to Physicians Mutual®. The transaction is subject to negotiation and execution of a definitive purchase agreement, completion of due diligence and regulatory approval. The transaction is expected to be completed in the second quarter of 2010. Terms of the transaction were not announced.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ornob Proteek Roy, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Ornob Proteek Roy, MD 1225 Harding Pl, Ste 3100, Charlotte, NC 28204-2826 Ph: (704) 355-8686 |
News Archive
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
Cancer Therapeutics, Inc. (OTCBB: CTHP), an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
The University of Pennsylvania Upstart Program announces TransCare Partners LLC to broaden the use of the Transitional Care Model developed at the University of Pennsylvania School of Nursing. The Model, developed over 20 years by Dr Mary Naylor, has been clinically proven to reduce hospital re- admissions by up to 30% while producing substantial savings for hospitals and Medicare.
Unitrin, Inc. today announced that it has reached an agreement in principle to sell its health insurance subsidiary, Reserve National Insurance Company, to Physicians Mutual®. The transaction is subject to negotiation and execution of a definitive purchase agreement, completion of due diligence and regulatory approval. The transaction is expected to be completed in the second quarter of 2010. Terms of the transaction were not announced.
› Verified 3 days ago
Mark J. Makhuli, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1225 Harding Pl, Ste 3100, Charlotte, NC 28204 Phone: 704-355-8686 | |
Dr. George Albert Dasher, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 10512 Park Rd, Suite 113, Charlotte, NC 28210 Phone: 704-541-8207 | |
Dr. Craig H Robson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 335 N Caswell Rd, Charlotte, NC 28204 Phone: 704-384-7980 | |
Peter Earl Clark, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1021 Morehead Medical Dr, Ste 6100, Charlotte, NC 28204 Phone: 980-442-2000 | |
Jonathan Pierce Walker, MD Urology Medicare: Medicare Enrolled Practice Location: 1001 Blythe Blvd, Charlotte, NC 28203 Phone: 704-446-5070 | |
E Matthew Dilizia, MD Urology Medicare: Medicare Enrolled Practice Location: 10660 Park Rd Ste 4100, Charlotte, NC 28210 Phone: 704-541-8207 Fax: 704-540-8288 | |
Dr. Lawrence Andrew Eskew, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 335 N Caswell Rd, Charlotte, NC 28204 Phone: 704-384-7980 Fax: 704-384-7985 |